What end of Eli Lilly's weight-loss drug shortage means for the competition
The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 ...
The Hill2d
Mounjaro and Zepbound no longer in shortage
After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ... to the company for comment. Eli Lilly, the manufacturer of ...
Modern Healthcare3d
Eli Lilly weight-loss drug shortage ends, shaking up telehealth
Eli Lilly & Co.’s blockbuster weight-loss ... The Food and Drug Administration said Wednesday that the shortage of Lilly’s Zepbound and Mounjaro is resolved. The agency added that there ...
Drugmaker Lilly slates another $4.5B for manufacturing and drug development improvements
Eli Lilly is pouring another $4.5 billion into expanding manufacturing and development as the drugmaker rakes in billions ...
Pharmaceutical Technology on MSN1d
NHS proposes phased launch for Eli Lilly’s Mounjaro
The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...
5 things to know before the stock market opens Thursday
OpenAI closed its funding round at a $157 billion valuation. Tesla shares dropped after the EV maker missed estimates on ...
Eli Lilly plans $4.5 billion facility in LEAP District, bringing investment to $13 billion
The $4.5 billion investment will create the Lilly Medicine Foundry, a center that will combine research and manufacturing ...
Evaluating Eli Lilly Against Peers In Pharmaceuticals Industry
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...